Cargando…
Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
Cardiovascular diseases are responsible for increased morbidity and mortality in people with diabetes. Diabetic macrovasculopathy is associated with structural and functional changes in large arteries, which causes endothelial dysfunction, increased arterial stiffness, or decreased arterial distensa...
Autores principales: | Rahman, Sayeeda, Ismail, Aziz Al-Shafi, Rahman, Abdul Rashid A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822214/ https://www.ncbi.nlm.nih.gov/pubmed/20165647 http://dx.doi.org/10.4103/0973-3930.54287 |
Ejemplares similares
-
Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?
por: Rahman, Sayeeda, et al.
Publicado: (2010) -
Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011) -
Plant Microbiome Engineering: Hopes or Hypes
por: Afridi, Muhammad Siddique, et al.
Publicado: (2022) -
Hope and hype
por: De Clercq, Erik
Publicado: (2006) -
Cytokines in Schizophrenia: Hope or Hype?
por: Koola, Maju Mathew
Publicado: (2016)